Allergan Inc (NYSE:AGN)

235.41
Delayed Data
As of Mar 05
 -0.27 / -0.11%
Today’s Change
115.94
Today|||52-Week Range
236.45
+10.73%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues5.4B5.8B6.3B7.2B
 
 
 
 
 
Cost of Goods Sold622.9M650.1M648.9M842.4M
 
 
 
 
 
Depreciation And Amortization253.4M256.6M254.6M--
 
 
 
 
 
Operating ExpensesGross Income4.5B4.9B5.4B6.4B
 
 
 
 
 
General Expenses3.1B3.2B3.5B4.0B
 
 
 
 
 
Other Operating Expenses0.000.000.00112.4M
 
 
Research And Development857.8M927.1M1.0B1.2B
 
 
 
 
 
Total Operating Expenses4.0B4.1B4.4B5.0B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income1.4B1.7B1.9B2.3B
 
 
 
 
 
Extraordinary Credit24.9M0.00----
 
 
Extraordinary Charge-76.3M-98.5M-111.1M-245.0M
 
 
 
 
 
Interest Expense On Debt89.1M79.6M89.9M69.4M
 
 
 
 
 
Other Expenses-16.3M-7.8M-9.2M41.7M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income1.3B1.5B1.7B2.0B
 
 
 
 
 
Income Taxes-361.6M-430.8M-458.3M-456.7M
 
 
 
 
 
Minority Interest-3.6M-3.7M-3.6M-4.6M
 
 
 
 
 
Discontinued Operations0.000.0014.1M--
 
 
Extraordinary Items0.000.00-297.9M-3.8M
 
 
 
Net Income934.5M1.1B1.3B1.5B
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS304.4M301.5M296.8M297.6M
 
 
 
 
 
Shares To Calculate EPS Diluted310.2M307.1M301.8M304.0M
 
 
 
 
 
 
Earnings Per ShareEPS$3.01$3.58$3.26$5.01
 
 
 
 
 
EPS Diluted$3.01$3.58$4.25$5.03
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account